UK Prospective Diabetes Study Group. UKPDS 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease [published correction appears in Diabetes. 1996;45:1655]. Diabetes. 1995;44:1249-1258.
2.
Riddle MC.The underuse of insulin therapy in North America. Diabetes Metab Res Rev.2002;18:S42-S49.
3.
United Kingdom Prospective Diabetes Study Group. UKPDS 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ.1995;310:83-88.
4.
Diabetes Attitudes, Wishes, and Needs (DAWN) Study. Barriers to treatment. Available at: http://www.dawnstudy.com. Accessed September 29, 2005.
5.
Polonosky WH, Fisher L, Guzman S, et al.Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care.2005;28:2543-2545.
6.
Polonosky WH, Jackson RA.What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes.2004;22:147-150.
7.
Wallace TM, Matthews DR.Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. Q J Med.2000;93:369-374.
8.
Koro CE, Bowlin SJ, Bourgeois N, Fedder DO.Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care.2004;27:17-20.
9.
Funnell MM, Kruger DF, Spencer M.Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ.2004;30: 274-280.
10.
Summers KH, Szeinbach SL, Lenox SM.Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther.2004;26:1498-1505.
11.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;352:837-853.
12.
Riddle MC, Rosenstock J, Gerich J, on behalf of the Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care.2003;26:3080-3086.
13.
Raskin P, Allen E, Hollander P, et al, for the INITIATE Study Group. Initiating insulin therapy in type 2 diabetes. Diabetes Care.2005;28:260-265.
14.
Yki-Jarvinen H, Dressler A, Ziemen M, for the HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care.2000;23:1130-1136.
15.
Janka HU, Plewe G, Riddle MC, et al.Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care.2005; 28:254-259.
16.
Yki-Jarvinen H, Ryysy L, Nikkila K, et al.Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med.1999;130:389-396.
17.
Aviles-Santes L, Sinding J, Raskin P.Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med.1999;131:182-188.
18.
Stratton IM, Adler AI, Neil HAW, et al, on behalf of the UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ.2000;321:405-412.
19.
White JR, Davis SN, Cooppan R, et al, the Diabetes Consortium Medical Advisory Board. Clarifying the role of insulin in type 2 diabetes management. Clin Diabetes.2003;21:14-21.
20.
Malmberg K, for the DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ.1997;314:1512-1515.
21.
Malmberg K, Ryden L, Efendic S, et al.Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol.1995;26:57-65.
22.
Van den Berghe G, Wouters P, Weekers F, et al.Intensive insulin therapy in critically ill patients. N Engl J Med.2001;345: 1359-1367.
